Charles River Laboratories Announces Strong Fourth-Quarter and Full-Year 2002 Results and Provides Positive Outlook for 2003.

Extract


Charles River Laboratories Announces Strong Fourth-Quarter and Full-Year 2002 Results and Provides Positive Outlook for 2003.

Business Editors & Health/Medical Writers

BIOWIRE2K

WILMINGTON, Mass.--(BUSINESS WIRE)--Feb. 3, 2003

Charles River Laboratories International, Inc. (NYSE:CRL) today reported fourth-quarter 2002 income before extraordinary item of $17.5 million, a 58.3% increase over the $11.1 million reported in the fourth quarter of 2001. Earnings per share before extraordinary item rose 50.0% to $0.36 per diluted share from $0.24 per diluted share reported last year. Net income for the fourth quarter was $17.5 million, or $0.36 per diluted share, compared to $8.9 million, or $0.19 per diluted share, in the fourth quarter of 2001. Last year's fourth quarter included an extraordinary loss, net of tax benefit, of $2.1 million for early retiremen...

See the full content of this document


ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2013, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company